Matches in Nanopublications for { ?s ?p "Ivacaftor (also known as Kalydeco or VX-770) is a drug for the treatment of cystic fibrosis, developed by Vertex Pharmaceuticals and the Cystic Fibrosis Foundation. FDA approved on January 31, 2012."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.